Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03265886
Other study ID # MFM-IRB, MS/17.05.143
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date September 17, 2018

Study information

Verified date November 2019
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite PH adjustment of local anesthetic solution improves the quality of the block in all respects with special advantage of early onset of sensory and motor block, adequate level of analgesia, and prolongation of duration of block, the effect of warmed bupivacaine should have the same effect which have not been evaluated on supraclavicular plexus block for upper limb surgery.

The warmed bupivacaine used in supraclavicular plexus block may reduce sensory and motor block onset and prolong the duration of analgesia when compared to bupivacaine at operating room temperature.


Description:

The aim of this study is to compare the effect of warm bupivacaine 0.5% at 37◦C versus bupivacaine 0.5% at operating room temperature at 23◦C on ultrasound-guided supraclavicular plexus block characteristics as regard sensory block onset time, motor block onset time, duration of sensory and motor block , effective duration of analgesia, total analgesics requirement, complications and side effects.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date September 17, 2018
Est. primary completion date June 9, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists physical class I or II

Exclusion Criteria:

- Patient refusal.

- Pregnancy

- Neuromuscular diseases (as myopathies, myasthenia gravies…)

- Hematological diseases

- Bleeding disorders

- Coagulation abnormality.

- Psychiatric diseases.

- Local skin infection

- Sepsis at site of the block.

- Known intolerance to the study drugs.

- Body Mass Index > 40 Kg/m2.

- Bilateral upper limb injury to be performed at the same procedure.

Study Design


Related Conditions & MeSH terms

  • Surgery to the Distal One Third of the Upper Limb

Intervention

Drug:
Warm bupivacaine at (37°c)
Bupivacaine 0.5%, 30 mL, warmed to 37?C for 20 minutes. The empty syringes and needles, in their packaging, will be held at the same temperature before initiating the block.
Bupivacaine at operating room temperature (23°c)
Bupivacaine 0.5%, 30 ml held in crash shelf of the operating room temperature at 23?C. The empty syringes and needles will be held in the same temperature before use.

Locations

Country Name City State
Egypt Mansoura University, Faculty of Medicine Mansourah DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to onset of sensory block defined as the time interval between the end of local anesthetic injection and the loss of sensation to pinprick (sensory score = 1) for 30 min following injection
Secondary Time to onset of motor block defined as time interval between the end of local anesthetic injection and (motor score = 1) in the distributions of all 4 peripheral nerves. For 3 hours after the injection of local anesthetic
Secondary Heart rate For 3 hours after the injection of local anesthetic
Secondary Blood pressure For 3 hours after the injection of local anesthetic
Secondary oxygen saturation in the peripheral blood For 3 hours after the injection of local anesthetic
Secondary Duration of sensory block defined as the interval between end of injection and complete end of sensory block (score=2) For 24 hours after the injection of local anesthetic
Secondary Duration of motor block defined as the interval between end of injection and complete recovery of normal motor function (score=0), respectively. For 24 hours after the injection of local anesthetic
Secondary The severity of postoperative pain will be measured and recorded by using a 100-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 100 indicates the worst possible pain. For 24 hours after the injection of local anesthetic
Secondary Time for first analgesic request Time to the first receiving of rescue analgesic from the time of blockade For 24 hours after the injection of local anesthetic
Secondary Total analgesics received Cumulative use of rescue analgesics after performing the blockade for 24 hrs after the injection of local anesthetic
Secondary Satisfaction Score Using score including 5-Excellent, 4-Very Good, 3-Good, 2-Fair, and 1-Poor for 48 hrs after the injection of local anesthetic